A raise of $300M gives repurchase authority to Valeant Pharma
Earlier on Monday, Valeant Pharmaceuticals International Inc. announced that a $300 million raise has been approved for the repurchase of
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine